XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2020   350,000          
Beginning balance at Dec. 31, 2020   $ 10,924          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ (853)          
Ending balance (in shares) at Mar. 31, 2021   350,000          
Ending balance at Mar. 31, 2021   $ 11,777          
Beginning balance (in shares) at Dec. 31, 2020     49,279,453        
Beginning balance at Dec. 31, 2020 $ 288,316   $ 49 $ (43,270) $ 651,416 $ (330,921) $ 11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (163,565)         (164,465) 900
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value 853       853    
Dividend on Series A Redeemable Convertible Preferred Stock (260)       (260)    
Compensation expense for share-based awards 450       450    
Ending balance (in shares) at Mar. 31, 2021     49,279,453        
Ending balance at Mar. 31, 2021 124,088   $ 49 (43,270) 650,753 (495,386) 11,942
Beginning balance (in shares) at Dec. 31, 2021   350,000          
Beginning balance at Dec. 31, 2021   $ 14,753          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ (1,151)          
Ending balance (in shares) at Mar. 31, 2022   350,000          
Ending balance at Mar. 31, 2022   $ 15,904          
Beginning balance (in shares) at Dec. 31, 2021     48,807,748        
Beginning balance at Dec. 31, 2021 430,475   $ 49 (47,281) 648,389 (181,724) 11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (73,266)         (73,266)  
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value 1,151       1,151    
Dividend on Series A Redeemable Convertible Preferred Stock $ (700)       (700)    
Issuance of common stock for vesting of restricted stock units, (in shares)     15,000        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     292,667        
Shares withheld related to net share settlement of share-based awards (in shares) (18,770)            
Shares withheld related to net share settlement of share-based awards $ (72)       (72)    
Compensation expense for share-based awards 1,174       1,174    
Repurchase of common stock (in shares)     (2,341,715)        
Repurchase of common stock (10,988)   $ (2) (10,986)      
Ending balance (in shares) at Mar. 31, 2022     46,754,930        
Ending balance at Mar. 31, 2022 $ 345,472   $ 47 $ (58,267) $ 647,640 $ (254,990) $ 11,042